AMENDMENT NO. 2 TO STOCKHOLDER RIGHTS AGREEMENT
Exhibit 99.3
AMENDMENT NO. 2 TO
STOCKHOLDER RIGHTS AGREEMENT
STOCKHOLDER RIGHTS AGREEMENT
This Amendment No. 2 to Stockholder Rights Agreement (the “Amendment”), dated as of October
14, 2009, by and between OXiGENE, Inc., a Delaware corporation (the “Company”), and American Stock
Transfer & Trust Company, LLC (the “Rights Agent”), amends that certain Stockholder Rights
Agreement, dated as of March 24, 2005, as amended as of October 1, 2008, between the Company and
the Rights Agent (as so amended, the “Agreement”).
WHEREAS, the parties desire to amend the Agreement, pursuant to Section 27 thereof, in
connection with the transactions described in that certain Agreement and Plan of Merger by and
among the Company, OXiGENE Merger Sub, Inc., a Delaware corporation, VaxGen, Inc., a Delaware
corporation (“VaxGen”) and Xxxxx Xxxxx as the Stockholder Representative, dated as of even date
herewith (the “Merger Agreement”).
NOW THEREFORE, the parties hereby agree as follows:
1. Definition of “Acquiring Person.” The definition of “Acquiring Person” as set
forth in Section 1(a) of the Agreement is hereby further amended by adding the following to the end
thereof:
“Notwithstanding anything herein to the contrary, none of VaxGen, Inc. (“VaxGen”) nor any of
the persons listed on Exhibit A hereto shall be deemed to be an Acquiring Person solely by
virtue of the transactions contemplated by the Agreement and Plan of Merger by and among the
Company, OXiGENE Merger Sub, Inc., VaxGen and Xxxxx Xxxxx as the Stockholder Representative, dated
as of October 14, 2009 (the “VaxGen Merger Agreement”), including but not limited to, where
applicable, the acquisition of Common Stock by such persons or entities pursuant to the VaxGen
Merger Agreement.”
2. Definition of “Stock Acquisition Date.” The definition of “Stock Acquisition Date”
as set forth in Section 1(hh) of the Agreement is hereby further amended by adding the following to
the end thereof:
“Notwithstanding anything herein to the contrary, the execution, delivery and performance by
the persons listed on Exhibit A hereto of those certain Voting Agreements, dated as of
October 14, 2009, between such persons and the Company in connection with the transactions
contemplated by the VaxGen Merger Agreement (the “Voting Agreements”), shall not be deemed, by
itself, to constitute or lead to a Stock Acquisition Date under this Agreement.”
3. Definition of “Distribution Date.” The definition of “Distribution Date” as set
forth in Section 3(a) of the Agreement is hereby further amended by adding the following to the end
thereof:
“Notwithstanding anything herein to the contrary, the execution, delivery and performance by
the persons listed on Exhibit A hereto of the Voting Agreements shall not be deemed, by
itself, to constitute or lead to a Distribution Date under this Agreement.”
4. Ratification. The parties hereby ratify and confirm in all respects the Agreement,
as amended by this Amendment.
5. Governing Law. This Amendment shall be deemed to be a contract made under the laws
of the State of Delaware and for all purposes shall be governed by and construed in accordance with
the laws of such State applicable to contracts to be made and performed entirely within such State.
6. Counterparts. This Amendment may be executed in any number of
counterparts and each of such counterparts shall for all purposes be deemed to be an original, and
all such counterparts shall together constitute but one and the same instrument.
7. Descriptive Headings. Descriptive headings of the several Sections of
this Amendment are inserted for convenience only and shall not control or affect the meaning or
construction of any of the provisions hereof.
[remainder left intentionally blank]
IN WITNESS WHEREOF, the parties have entered into this Second Amendment to Stockholder Rights
Agreement as of the date first stated above.
OXiGENE, INC. |
|||||
By: | /s/ Xxxxx Xxxxxxxxx | ||||
Xxxxx Xxxxxxxxx, M.D., Ph.D., Chief Executive Officer | |||||
AMERICAN STOCK TRANSFER & TRUST COMPANY, LLC |
|||||
By: | /s/ Xxxxx Xxxxxxxxx | ||||
Xxxxx Xxxxxxxxx, Vice President | |||||
EXHIBIT A
Xxxxx Xxxxx
Xxxx Xxxxxxx
Xxxxxxxx Xxxxxx
Xxxxx Xxxxxx
Xxxx XxXxxxxxx
Xxxx Xxxxxxx
Xxxxxxxx Xxxxxx
Xxxxx Xxxxxx
Xxxx XxXxxxxxx